Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil

Immunogenicity and safety of a recombinant, live-attenuated, tetravalent dengue disease vaccine (CYD-TDV) was evaluated in children/adolescents in Brazil. In this observer-blind, placebo-controlled, phase II single-center study, children/adolescents (ages 9–16 years) were randomized to receive CYD-T...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Dayan, Gustavo H., Garbes, Pedro, Noriega, Fernando, de Sadovsky, Ana Daniela Izoton, Rodrigues, Patricia Marques, Giuberti, Camila, Dietze, Reynaldo
Format: Artigo
Sprog:Inglês
Udgivet: The American Society of Tropical Medicine and Hygiene 2013
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854882/
https://ncbi.nlm.nih.gov/pubmed/24189367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.13-0304
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker